Secondary Hyperparathyroidism in Chronic Dialysis Patients: Results of the Italian FARO Survey on Treatment and Mortality-Reference-Cited by-同舟云学术

Secondary Hyperparathyroidism in Chronic Dialysis Patients: Results of the Italian FARO Survey on Treatment and Mortality

Published:2011 Issue:2 Volume:32 Page:124-132
ISSN:1421-9735
Container-title:Blood Purification
language:en
Short-container-title:Blood Purif

Author:

Brancaccio Diego,Cozzolino Mario,Cannella Giuseppe,Messa Piergiorgio,Bonomini Mario,Cancarini Giovanni,Caruso Maria Rosa,Cascone Carmelo,Costanzo Anna Maria,di Luzio Paparatti Umberto,Mazzaferro Sandro

Publisher

S. Karger AG

Subject

Nephrology,Hematology,General Medicine

Reference28 articles.

1. Metabolic Bone Disease in Chronic Kidney Disease

2. Vitamin D

3. Cardiovascular calcification in end‐stage renal disease

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological profile of upacicalcet, a novel positive allosteric modulator of calcium-sensing receptor, in vitro and in vivo;European Journal of Pharmacology;2023-10

2. Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model;Bone;2023-02

3. Efficacy and safety of intravenous paricalcitol treatment in Chinese hemodialysis patients: a real-world database analysis;Annals of Palliative Medicine;2022-01

4. A Higher Concentration of Dialysate Magnesium to Reduce the Frequency of Muscle Cramps: A Narrative Review;Canadian Journal of Kidney Health and Disease;2020-01

5. Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study;International Urology and Nephrology;2019-06-03